Xenon Pharmaceuticals Inc.

Related records

Trials (23)

• A Crossover Study to Evaluate the Safety, Tolerability and Efficacy of XPF-002 in Subjects With Postherpetic Neuralgia (PHN)
• A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
• A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel
• A Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 in Major Depressive Disorder
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
• An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE
• An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
• An Open-Label Study of Azetukalner in Major Depressive Disorder
• An Open-label Study of XEN1101 in Epilepsy
• Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in Patients With Primary/Inherited Erythromelalgia
• Safety and Efficacy Study of XPF-001 to Treat Pain Following Wisdom Tooth Extraction
• Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of XEN1101.
• Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of XEN901
• Safety, Tolerability, Pharmacokinetics and Effects on Transcranial Magnetic Stimulation of Oral Doses of XEN1101
• Single and Multiple Ascending Dose Safety Study of XPF-001 in Healthy Volunteers